Sarepta therapeutics announces third quarter 2021 financial results and recent corporate developments

Cambridge, mass., nov. 03, 2021 (globe newswire) -- sarepta therapeutics, inc. (nasdaq:srpt), the leader in precision genetic medicine for rare diseases, today reported financial results for the third quarter of 2021.
SRPT Ratings Summary
SRPT Quant Ranking